A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

Clinical trial NCT02444793 · TERMINATED

Trial details

NCT number: NCT02444793
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors

Start date: 2015-05-01
Primary completion: 2017-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.